Gene Query: HIST1H2AH

Dataset Description Geneva Score
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 111.54
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 111.54
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 100.93
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 96.9
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 89.64
Uridylation by TUT4 and TUT7 marks mRNA for degradation 89.2
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 84.41
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 81.58
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 81.58
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 79.74
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 79.04
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 77.86
Impact of dieldrin on transcription in Jurkat T cells 74.04
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 72.42
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 72.42
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 66.87
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 60.54
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 57.62
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 55.67
Studying the selectivity of a small molecule Synucleozid on transcriptome 54.64
Transcriptome analysis of Zika infected neural stem cells 52.2
Zika infected neural stem cells 52.2
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 51.87
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 51.85
Expression and functions of long noncoding RNAs during human T helper cell differentiation 50.79
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 49.46
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 48.25
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 48.11
Endothelial gene expression analysis 48.11
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 47.06
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 47.04
Gene induction by the USP6 oncogene in response to interferon 45.83
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 45.33
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 43.89
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 43.58
Role of XRN2 ribonucleolytic activity in RNA metabolism 43.51
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 42.32
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 40.59
Role for citron kinase in prostate cancer growth 40.45
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 39.48
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 39.37
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 39.23
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 38.92
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 38.71
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 38.38
RNA-seq of resting and activated CD4+ T cells +-JQ1 37.37
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 37.04
A code of mono-phosphorylation modulates the function of RB. 36.68
NRDE2 negatively regulates nuclear exosome functions 36.18
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 36.15
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 36.15
Tracking distinct RNA populations using efficient and reversible covalent chemistry 36.11
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 35.99
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 35.22
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 34.41
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 33.99
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 33.83
RNA-sequencing of formalin fixed human primary melanoma tissue 33.48
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 33.06
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 33.04
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 32.57
Retinoic acid suppresses MYB in adenoid cystic carcinoma 32.57
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 31.78
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 31.24
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 31.14
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 31.11
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 30.64
Differentiation enhances Zika virus infection in neuronal brain cells 29.99
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 29.7
Identification of HOXB13 target genes responsive to BET inhibitors 29.57
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 29.54
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 29.51
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 29.51
CD95/Fas ligand mRNA is toxic to cells 29.44
U1 snRNP telescripting regulates size-function stratified human genome 29.25
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 28.92
circRNA profile in hypopharyngeal cancer 28.77
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency [RNA-seq] 28.71
Low cytosolic folate cycling is a hallmark of U251 glioblastoma cells reprogramming towards pluripotency 28.71
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 28.67
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 28.38
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 28.16
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 27.94
Effect of BB608 on Gene Expression in HNSCC Cell Line 27.9
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 27.68
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 27.68
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 27.26
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 27.08
Genes significantly down or Up-regulated upon RNF219 knockdown 26.85
MYCi361 regulates MYC target genes 26.51
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 26.19
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 26.19
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 25.99
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 25.91
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 25.72
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 25.25
Solid phase chemistry to covalently and reversibly capture thiolated RNA 25.16
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 25.01
The interplay between SOX4 and SMAD3 in the context of breast cancer 24.98
Mapping interactions for the TNIP2 hub protein 24.81
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 24.77
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 24.1
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 24.07
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 23.67
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 23.64
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 23.64
p63 controls the enhancer landscape during keratinocyte differentiation 22.75
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 22.7
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 22.39
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 22.22
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 22.22
Reassessment of Exosome Composition 21.55
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 21.26
Dynamic 3D chromosomal landscapes in acute leukemia 21.13
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 21.13
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of HSCe) 20.65
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 20.5
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 20.07
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 19.99
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  19.79
Ribosomal footprinting of CN34-Parental and CN34-LM1a 19.78
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 19.57
TT-Seq captures the human transient transcriptome 19.54
Ribosomal footprinting of MDA-Parental and MDA-LM2 19.36
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 19.16
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 19.14
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 18.6
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 18.54
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 18.35
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 18.35
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 18.16
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 18.04
Gene expression changes caused by KRAS in MCF-10A 18.01
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 17.86
RNA-seq of YB5 cells treated with Proscillaridin A 17.56
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 17.49
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 17.46
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 17.4
RNA-Seq with and without RNase treatment in PCa cell lines 17.34
RNA-sequencing in irradiated and normal A549 cells. 17.3
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 17.21
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 17.08
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 16.93
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 16.92
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 16.78
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 16.78
Differential responses of human fetal brain neural stem cells to Zika virus infection 16.38
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 16.31
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 16.3
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 16.29
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 16.02
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 15.81
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 15.81
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 15.77
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 15.71
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 15.6
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 15.59
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 15.59
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 15.58
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 15.58
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 15.51
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 15.17
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 14.97
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 14.87
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 14.65
Short and Long RNA sequencing of human mature erythrocytes 14.57
HNRNPM-regulated splicing dependencies in prostate cancer 14.56
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 14.56
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 14.54
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 14.48
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 14.46
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 14.03
CircRNAome diversity in human mature B-cells, T-cells and monocytes 14.0
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 13.91
Landscape of H3K4me3 in human CD19 cells 13.57
RNA-seq in SUNE-1 cells after downregulation of DANCR expression 13.51
Combined use of astragalus polysaccharide and berberine attenuates insulin resistance in IR-HepG2 cells via regulation of the gluconeogenesis signaling pathway 13.31
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 13.29
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 13.26
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 13.21
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 13.2
MYCi975 regulates MYC target genes 13.07
HEK293 Heat-shock experiment 13.01
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 12.95
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 12.95
Widespread intronic polyadenylation diversifies immune cell transcriptomes 12.73
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 12.64
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 12.64
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 12.6
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 12.31
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 12.25
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 12.23
Transcriptome analysis upon C6orf203 silencing 12.09
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 12.08
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 12.08
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 12.08
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 12.04
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 12.04
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 12.03
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 11.96
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 11.96
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 11.83
Landscape and variation of RNA secondary structure across the human transcriptome 11.79
Gene expression profiling of human and murine in vitro muscle differentiation 11.72
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 11.69
11.51
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 11.49
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 11.41
Comprehensive comparative analysis of 5’ end RNA sequencing methods 11.4
Mitochondrial dsRNA triggers antiviral signalling in humans 11.4
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 11.34
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 11.33
Differentially expressed genes post knock down of lincDUSP26 11.32
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 11.22
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 11.22
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 11.18
SRSF1 role in cellular gene expression and splicing 11.14
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 11.13
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 11.13
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 11.0
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 10.82
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 10.7
Hijacking of stress response machinery by oncogenes in acute leukaemia 10.67
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 10.67
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 10.67
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 10.67
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 10.47
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 10.47
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 10.46
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  10.34
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 10.32
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 10.31
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 10.31
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 10.28
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 10.26
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 10.26
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 10.26
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 9.98
Oncogenic MYC induces a dependency on the spliceosome in human cancer 9.83
High-throughput sequencing of PROMPT-enriched samples. 9.73
Global transcriptome analysis of WT versus HEB-/- hESCs 9.67
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 9.58
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 9.58
Global response to chemotherapy-induced apoptosis 9.55
Transcriptome landscape of HeLa response upon triamcinolone acetonide 9.52
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 9.5
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 9.49
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 9.46
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 9.37
Human cell line and subcutaneous tumor 9.35
BAF controls genome accessibility 9.29
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 9.26
Glioblastoma stem cells infected by ZIKA virus 9.25
6mer seed toxicity in tumour suppressive microRNAs 9.24
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 9.08
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 9.02
Transcriptome analysis of H9 hESC derived cerebral organoids 8.99
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 8.98
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 8.91
Enhancer activation during EGF response 8.91
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 8.88
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 8.86
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 8.75
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 8.7
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 8.66
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 8.65
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 8.61
A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection 8.56
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 8.56
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 8.55
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 8.52
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 8.52
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 8.49
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 8.49
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 8.46
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 8.42
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 8.42
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 8.41
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 8.41
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 8.3
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 8.3
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 8.26
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 8.25
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 8.22
Splicing and epigenetic factors jointly regulate epidermal differentiation 8.22
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 8.22
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 8.22
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 8.21
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 8.17
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 8.1
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 8.1
Hypoxic transcriptome of SQ20B human head and neck cancer cells 8.05
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 8.03
Cajal bodies are linked to genome conformation [RNA-Seq] 8.01
Cajal bodies are linked to genome conformation 8.01
Transcriptome of iPSC-derived Cerebral Organoids with Heterozygous Knockout in CHD8 7.99
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 7.95
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 7.94
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 7.92
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 7.89
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 7.88
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 7.87
TAF1 is critical for AE driven leukemogenesis 7.87
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 7.87
A role for ZNF598 in post-transcriptional gene regulation 7.83
Gene expression profiling study by RNA-seq in PDX model based diffuse type gastric cancers. 7.81
p53 activity results in DNA replication fork processivity 7.72
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 7.67
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 7.61
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 7.61
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 7.6
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 7.58
Epigenome regulation during epidermal lineage commitment [RNA-seq] 7.57
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 7.56
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 7.53
The Wnt/β-catenin and RAS-ERK Pathways were Activated in Tissues of Chemotherapy-Resistant Gastric Cancer PDX Tumor 7.5
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 7.47
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 7.47
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 7.46
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 7.42
DRB/GRO-Seq -/+ UV 7.27
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 7.23
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 7.23
EWS-Fli and LNC regulated genes in comparison to GFP samples 7.21
Entrectinib Resistance in a Neuroblastoma Xenograft Model 7.18
m6A-dependent regulation of messenger RNA stability 7.1
Genome-wide identification of cancer-specific alternative splicing in circRNA 7.06
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 7.03
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 7.0
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 6.89
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 6.88
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 6.77
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 6.77
Transcription-dependent control of stem cell self-renewal and differentiation by the splicing factor U2AF1 6.74
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 6.71
Epigenome regulation during epidermal lineage commitment 6.67
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 6.59
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 6.57
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 6.52
Role of microRNAs in the interaction between Salmonella and the host cell 6.48
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 6.46
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 6.45
Gene expression profile of human iPSC-derived nephron progenitor cells 6.4
Selective expression of long non-coding RNAs in a breast cancer cell progression model 6.4
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 6.39
Cerebellar differentiation in Ataxia-Telangiectasia 6.35
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 6.31
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 6.19
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 6.13
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 6.12
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 5.97
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 5.94
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 5.94
Differential Gene Expression between MCF10A and MCF7 cells 5.86
Identification of long noncoding RNAs regulated by p53 5.85
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 5.76
ADAR1-editing of cellular and measles virus-derived duplex RNA 5.76
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 5.76
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 5.62
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 5.56
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 5.48
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 5.47
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 5.46
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 5.46
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 5.38
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 5.38
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 5.25
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 5.25
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 5.22
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 5.22
The pause-initiation limit restricts transcription activation in human cells 5.2
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 5.19
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 5.09
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 5.0
RNA editing in nascent RNA affects pre-mRNA splicing 4.99
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 4.99
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 4.98
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 4.88
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 4.88
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 4.88
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 4.86
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 4.8
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 4.79
Universal alternative splicing of noncoding exons 4.76
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 4.75
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 4.67
Differential gene expression profiles in imatinib-resistant cell lines 4.61
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 4.49
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 4.47
4sUDRB-seq: measuring transcription elongation and initiation genomewide 4.45
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 4.44
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 4.44
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 4.44
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 4.42
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 4.38
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 4.38
PNET animal model: new insights (II) 4.2
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 4.19
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 4.18
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 4.11
Convergent roles of ATF3 and CSL in chromatin control of CAF activation 4.07
Convergent roles of ATF3 and CSL in chromatin control of CAF activation [RNA-seq] 4.07
Transcriptome profiling of A2M treated A549 Cell Line Samples 3.99
Microglia innatly develop within cerebral organoids 3.88
Gene expression analysis in response to hypoxic pathway inhibition 3.85
Human cells contain natural double-stranded RNAs with potential regulatory capacity 3.66
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 3.66
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 3.65
RNA sequencing analysis of selumetinib-resistant CRC cells lines 3.6
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 3.58
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 3.57
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 3.5
mRNA recovered upon RNF219 IP. [RNA-IP] 3.49
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 3.46
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 3.4
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 3.39
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 3.38
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 3.36
Dynamic reorganization of nuclear architecture during human cardiogenesis 3.36
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 3.3
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 3.28
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 3.13
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 3.12
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 3.04
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 3.04
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 2.95
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 2.92
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 2.84
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 2.84
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 2.8
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 2.8
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 2.78
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 2.76
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 2.76
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 2.75
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 2.72
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 2.71
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 2.68
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 2.68
The expression profiles of GBC liver metastasis 2.64
RNA-seq of MDA-MB-231 cells with TET1 knockout 2.6
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 2.41
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 2.4
Transcription elongation regulates genome 3D structure 2.32
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 2.05
BASP1 modifies the Tamoxifen response 2.05
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 2.0
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 1.97
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 1.97
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 1.96
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 1.7
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 1.69
Effect of BCL11B knockdown on transcriptome of human T-cell precursors 1.59
circNFIB suppresses lymphatic metastasis of pancreatic cancer 1.51
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 1.48
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.43
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 1.42
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 1.33
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 1.3
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 1.3
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.3
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 1.27
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 1.27
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 1.23
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 1.23
Determination of tRNA aminoacylation levels by high throughput sequencing 1.17
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 1.16
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 1.11
Identification of long noncoding RNAs in T-ALL cell lines 1.1
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 1.1
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 1.1
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 1.07
Inactivation of CFTR by CRISPR/Cas9 alters transcriptional regulation of inflammatory pathways and other networks 1.02
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 1.0
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.99
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.92
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.8
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.8
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.78
Time series total RNA sequencing of a differentiation of human embryonic stem cells towards trophoblast lineage 0.77
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.7
Aberrant splicing in B-cell acute lymphoblastic leukemia [B-ALL] 0.61
MHC Transcriptomic landscape at haplotype-specific resolution 0.6
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.57
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.54
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.53
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 0.5
Ribosome profiling upon inhibition of eIF4A 0.47
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.36
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.36
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 0.35
Total RNA-Seq data from leukemic patients with complex structural variants 0.26
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 0.23
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.2
Zika virus infection reprograms global transcription of host cells to allow sustained infection 0.15
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.1
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.1
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 0.09
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 0.03
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation